Peripheral venoarterial extracorporeal membrane oxygenation for periprocedural Cardiogenic shock during

Fernando J Verdugo1, Pabla Cataldo1, Jorge Sandoval1

  • 1Department of Cardiology, Instituto Nacional del Tórax, Santiago, Chile.

Revista Medica De Chile
|January 5, 2021
PubMed

Insights

Peripheral venoarterial extracorporeal membrane oxygenation (pVA-ECMO) can be a life-saving intervention for cardiogenic shock during interventional cardiology procedures. This study shows high survival rates, suggesting pVA-ECMO is a valuable bridge to recovery.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock (CS) is an uncommon but serious complication during cardiac catheterization procedures.
  • High-risk patients and complex interventions increase the likelihood of periprocedural CS.

Purpose of the Study:

  • To evaluate the clinical outcomes of patients treated with peripheral venoarterial extracorporeal membrane oxygenation (pVA-ECMO) for CS.
  • To assess the efficacy of pVA-ECMO as a bridge to recovery in interventional cardiology settings.

Main Methods:

  • Retrospective review of seven patients who received pVA-ECMO for CS between January 2014 and October 2018.
  • Analysis of patient demographics, procedural details, ECMO parameters, and clinical outcomes.

Main Results:

  • pVA-ECMO was initiated within 6 hours of the interventional cardiology procedure in all patients.
  • All patients had coronary artery disease; PCI complications occurred in five patients.
  • Survival rates were high at 85.7% at hospital discharge and 12-month follow-up, with minimal vascular access complications.

Conclusions:

  • Peripheral venoarterial extracorporeal membrane oxygenation (pVA-ECMO) is a viable option for managing periprocedural cardiogenic shock.
  • The use of pVA-ECMO in this series was associated with favorable clinical outcomes and high survival rates, serving as an effective bridge to recovery.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
252
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
129
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
536